FLUTICASONE PROPIONATE

FLUTICASONE PROPIONATE was reported 131686 times

FLUTICASONE PROPIONATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VAGINAL FLATULENCE 160 0.5281
1 SLEEP DISORDER THERAPY 90 0.4545
2 APPENDICOLITH 135 0.3488
3 DRUG THERAPY 109 0.3215
4 ANALGESIC THERAPY 102 0.3178
5 ADRENAL SUPPRESSION 156 0.1851
6 MITE ALLERGY 117 0.1786
7 PULMONARY VASCULITIS 88 0.1636
8 OVERLAP SYNDROME 100 0.1429
9 CHRONIC SINUSITIS 504 0.1341
10 FEMALE GENITAL TRACT FISTULA 223 0.1305
11 MYCOTIC ALLERGY 111 0.1298
12 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 252 0.1235
13 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 125 0.1177
14 DUST ALLERGY 112 0.1142
15 OBSTRUCTIVE SLEEP APNOEA SYNDROME 160 0.1097
16 NASAL OEDEMA 198 0.1095
17 INFUSION SITE DISCHARGE 173 0.0986
18 NASAL DISCOMFORT 778 0.0980
19 RESPIRATORY SYMPTOM 273 0.0959
20 TEMPERATURE REGULATION DISORDER 202 0.0906
21 NEPHROGENIC ANAEMIA 415 0.0895
22 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 477 0.0876
23 HYPERPARATHYROIDISM SECONDARY 216 0.0861
24 CONJUNCTIVITIS ALLERGIC 125 0.0843
25 NASAL INFLAMMATION 86 0.0814
26 RADICULOPATHY 212 0.0804
27 INFUSION SITE REACTION 237 0.0793
28 RHINALGIA 215 0.0782
29 NASAL ULCER 119 0.0746
30 NASAL POLYPS 362 0.0734
31 SPUTUM INCREASED 155 0.0716
32 NEURITIS 110 0.0712
33 FACET JOINT SYNDROME 228 0.0700
34 BRONCHIAL HYPERREACTIVITY 84 0.0698
35 ACUTE SINUSITIS 117 0.0678
36 ESSENTIAL HYPERTENSION 124 0.0677
37 REBOUND ACID HYPERSECRETION 204 0.0674
38 PRODUCT PACKAGE ASSOCIATED INJURY 148 0.0663
39 HYPERPHOSPHATAEMIA 142 0.0660
40 INFUSION SITE HAEMORRHAGE 216 0.0656
41 PERIPHERAL VENOUS DISEASE 268 0.0656
42 RHINITIS ALLERGIC 291 0.0653
43 NASAL DRYNESS 406 0.0647
44 FORCED EXPIRATORY VOLUME DECREASED 181 0.0638
45 PRODUCT DELIVERY MECHANISM ISSUE 340 0.0632
46 NASAL DISCHARGE DISCOLOURATION 87 0.0630
47 FOOD ALLERGY 485 0.0628
48 PROCTITIS 172 0.0613
49 SEASONAL ALLERGY 858 0.0606
50 BLOOD IMMUNOGLOBULIN E INCREASED 146 0.0602
51 UPPER-AIRWAY COUGH SYNDROME 485 0.0588
52 ANOSMIA 850 0.0587
53 INFUSION SITE BRUISING 126 0.0583
54 PARANASAL SINUS DISCOMFORT 212 0.0560
55 INFUSION SITE PRURITUS 174 0.0551
56 NASAL DISORDER 142 0.0533
57 MULTIPLE ALLERGIES 408 0.0520
58 BLEPHAROSPASM 325 0.0516
59 RETINITIS 88 0.0509
60 BLOOD PHOSPHORUS INCREASED 138 0.0505
61 SINUS OPERATION 119 0.0499
62 OBSTRUCTIVE AIRWAYS DISORDER 549 0.0493
63 MIDDLE EAR EFFUSION 108 0.0489
64 CYSTIC FIBROSIS 261 0.0471
65 NASAL SEPTUM DEVIATION 92 0.0470
66 SINUS PAIN 108 0.0463
67 INFUSION SITE SWELLING 291 0.0462
68 INFUSION SITE ERYTHEMA 386 0.0457
69 BURSITIS 554 0.0456
70 PRE-EXISTING CONDITION IMPROVED 280 0.0448
71 ASTHMA 4903 0.0433
72 ONYCHOMADESIS 182 0.0433
73 INFUSION SITE INFECTION 100 0.0430
74 PRODUCT ADMINISTRATION INTERRUPTED 336 0.0428
75 FULL BLOOD COUNT ABNORMAL 450 0.0425
76 INFUSION SITE PAIN 543 0.0421
77 SINUS HEADACHE 245 0.0412
78 SINUS DISORDER 801 0.0404
79 DEVICE INFUSION ISSUE 99 0.0399
80 BRONCHIECTASIS 266 0.0394
81 END STAGE RENAL DISEASE 720 0.0394
82 WHEEZING 2335 0.0393
83 DISLOCATION OF VERTEBRA 89 0.0390
84 FOETAL DEATH 201 0.0387
85 EPISTAXIS 2832 0.0378
86 RHINITIS 303 0.0375
87 SNORING 141 0.0373
88 PULMONARY FUNCTION TEST DECREASED 163 0.0372
89 BREAST CANCER STAGE III 241 0.0372
90 CUSHINGOID 119 0.0370
91 SPUTUM DISCOLOURED 351 0.0370
92 SLEEP APNOEA SYNDROME 705 0.0369
93 RHEUMATIC FEVER 163 0.0365
94 IRON DEFICIENCY 162 0.0360
95 MACULAR DEGENERATION 420 0.0351
96 INCREASED UPPER AIRWAY SECRETION 179 0.0348
97 EXERCISE TOLERANCE DECREASED 198 0.0344
98 PARANASAL SINUS HYPERSECRETION 131 0.0343
99 DIASTOLIC DYSFUNCTION 105 0.0340
100 SINUSITIS 3442 0.0336
101 NASAL CONGESTION 1968 0.0335
102 IMPAIRED QUALITY OF LIFE 479 0.0333
103 UPPER RESPIRATORY TRACT INFECTION 1538 0.0333
104 CHRONIC KIDNEY DISEASE 2502 0.0329
105 BREATH SOUNDS ABNORMAL 162 0.0328
106 PRODUCTIVE COUGH 1548 0.0324
107 HYPERCHOLESTEROLAEMIA 313 0.0324
108 BACK INJURY 349 0.0321
109 PLANTAR FASCIITIS 107 0.0319
110 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 228 0.0318
111 BRAIN NATRIURETIC PEPTIDE INCREASED 98 0.0318
112 ASTHMATIC CRISIS 116 0.0317
113 ORAL CANDIDIASIS 415 0.0315
114 IMMUNODEFICIENCY 468 0.0314
115 OBESITY 493 0.0309
116 EAR DISCOMFORT 314 0.0306
117 SINUS CONGESTION 410 0.0303
118 HYPERLIPIDAEMIA 361 0.0302
119 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 509 0.0299
120 PAROSMIA 223 0.0295
121 NORMOCHROMIC NORMOCYTIC ANAEMIA 88 0.0293
122 EXOSTOSIS 262 0.0287
123 EAR INFECTION 754 0.0283
124 HYPERVOLAEMIA 140 0.0283
125 RHINOVIRUS INFECTION 109 0.0280
126 RESPIRATORY TRACT INFECTION 729 0.0280
127 AORTIC STENOSIS 97 0.0278
128 SNEEZING 622 0.0277
129 DUODENAL ULCER PERFORATION 203 0.0273
130 EMPHYSEMA 271 0.0268
131 DYSPNOEA EXERTIONAL 1010 0.0268
132 FOLLICULITIS 280 0.0267
133 INTERVERTEBRAL DISC DEGENERATION 243 0.0262
134 ADRENAL INSUFFICIENCY 318 0.0262
135 RESPIRATORY TRACT CONGESTION 416 0.0262
136 EOSINOPHIL COUNT INCREASED 218 0.0261
137 FACIAL PAIN 233 0.0261
138 VITAMIN D DEFICIENCY 253 0.0259
139 CANDIDIASIS 104 0.0259
140 PRESCRIBED OVERDOSE 501 0.0259
141 HYPOPHOSPHATAEMIA 191 0.0258
142 PARAESTHESIA ORAL 371 0.0257
143 SECRETION DISCHARGE 321 0.0256
144 COELIAC DISEASE 249 0.0254
145 IRON DEFICIENCY ANAEMIA 234 0.0253
146 SPINAL OSTEOARTHRITIS 222 0.0252
147 AGEUSIA 623 0.0249
148 GASTROOESOPHAGEAL REFLUX DISEASE 2006 0.0249
149 DIVERTICULUM 177 0.0249
150 FIBROMYALGIA 604 0.0248
151 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1295 0.0248
152 RHINORRHOEA 1584 0.0245
153 DERMATITIS CONTACT 279 0.0244
154 WOUND INFECTION 267 0.0244
155 BENIGN PROSTATIC HYPERPLASIA 125 0.0242
156 MYASTHENIA GRAVIS 194 0.0240
157 HIATUS HERNIA 310 0.0239
158 TRICUSPID VALVE INCOMPETENCE 190 0.0239
159 BLOOD URIC ACID INCREASED 138 0.0239
160 RALES 137 0.0236
161 MUSCLE INJURY 194 0.0234
162 ARTERIOSCLEROSIS CORONARY ARTERY 155 0.0234
163 PRODUCT COMPLAINT 591 0.0233
164 BRONCHITIS 1714 0.0231
165 TASTE DISORDER 466 0.0229
166 DYSPHONIA 1337 0.0228
167 EAR DISORDER 104 0.0227
168 SLEEP TERROR 95 0.0225
169 EAR PAIN 437 0.0225
170 OSTEOPENIA 341 0.0224
171 IRRITABLE BOWEL SYNDROME 481 0.0224
172 HAEMOPTYSIS 620 0.0222
173 ACUTE RESPIRATORY FAILURE 421 0.0219
174 ATELECTASIS 210 0.0217
175 HELICOBACTER INFECTION 223 0.0217
176 OBSTRUCTION 86 0.0215
177 SKIN LACERATION 234 0.0215
178 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 108 0.0213
179 HAEMOGLOBIN INCREASED 97 0.0212
180 JOINT RANGE OF MOTION DECREASED 285 0.0212
181 COUGH 5939 0.0212
182 LIP DRY 191 0.0210
183 VASCULITIS 244 0.0209
184 CANDIDA INFECTION 353 0.0209
185 VAGINAL DISCHARGE 211 0.0208
186 GLUCOSE TOLERANCE IMPAIRED 123 0.0208
187 ENURESIS 84 0.0208
188 NEUROLOGICAL SYMPTOM 118 0.0206
189 GASTROENTERITIS VIRAL 372 0.0206
190 LIVE BIRTH 172 0.0205
191 INSURANCE ISSUE 314 0.0205
192 TENSION HEADACHE 88 0.0204
193 RED CELL DISTRIBUTION WIDTH INCREASED 85 0.0204
194 APPENDICITIS 191 0.0204
195 INFUSION SITE EXTRAVASATION 127 0.0204
196 DRY THROAT 207 0.0203
197 PULMONARY MASS 303 0.0203
198 NAIL DISORDER 177 0.0202
199 INCORRECT DRUG ADMINISTRATION RATE 86 0.0202
200 ROSACEA 94 0.0202
201 MIDDLE INSOMNIA 374 0.0200
202 VIRAL INFECTION 666 0.0200
203 ECONOMIC PROBLEM 303 0.0200
204 PHARYNGOLARYNGEAL PAIN 106 0.0199
205 OSTEOARTHRITIS 844 0.0199
206 HYPOXIA 697 0.0198
207 ANHEDONIA 518 0.0197
208 HORDEOLUM 85 0.0196
209 ONYCHOMYCOSIS 86 0.0196
210 POLYP 128 0.0195
211 OVERWEIGHT 105 0.0195
212 SPINAL COLUMN STENOSIS 92 0.0195
213 ROTATOR CUFF SYNDROME 249 0.0194
214 GOUT 346 0.0193
215 TROPONIN INCREASED 145 0.0190
216 THROAT IRRITATION 855 0.0190
217 LIGAMENT SPRAIN 187 0.0189
218 NEURALGIA 459 0.0189
219 CHOLECYSTITIS CHRONIC 126 0.0188
220 BRONCHOSPASM 268 0.0188
221 APHONIA 262 0.0188
222 CONTRAINDICATED PRODUCT ADMINISTERED 568 0.0187
223 VASCULAR DEVICE INFECTION 85 0.0187
224 OROPHARYNGEAL DISCOMFORT 169 0.0187
225 VIRAL UPPER RESPIRATORY TRACT INFECTION 88 0.0185
226 NIGHT SWEATS 596 0.0185
227 RENAL INJURY 549 0.0185
228 NODULE 241 0.0184
229 LUNG DISORDER 903 0.0184
230 CARPAL TUNNEL SYNDROME 258 0.0184
231 MUSCLE STRAIN 159 0.0184
232 BACTERIAL INFECTION 342 0.0183
233 PSEUDOMONAS INFECTION 157 0.0183
234 ARTERIOSCLEROSIS 172 0.0183
235 GLOSSODYNIA 409 0.0182
236 SWOLLEN TONGUE 569 0.0182
237 ARTHROPOD BITE 135 0.0182
238 SKIN ABRASION 86 0.0182
239 PULMONARY ALVEOLAR HAEMORRHAGE 102 0.0182
240 INCREASED TENDENCY TO BRUISE 167 0.0181
241 RESPIRATION ABNORMAL 125 0.0181
242 BLOOD PRESSURE INADEQUATELY CONTROLLED 109 0.0181
243 OROPHARYNGEAL PAIN 1671 0.0180
244 INITIAL INSOMNIA 185 0.0180
245 OXYGEN SATURATION DECREASED 1010 0.0180
246 RESPIRATORY SYNCYTIAL VIRUS INFECTION 156 0.0179
247 OEDEMA 971 0.0179
248 MENISCUS INJURY 110 0.0179
249 PULMONARY CONGESTION 235 0.0178
250 TOOTH ABSCESS 181 0.0178
251 SLEEP DISORDER 1250 0.0177
252 HEREDITARY ANGIOEDEMA 190 0.0177
253 CONCUSSION 137 0.0177
254 SOMNAMBULISM 116 0.0177
255 RETCHING 376 0.0176
256 DECREASED ACTIVITY 190 0.0176
257 POST-TRAUMATIC STRESS DISORDER 118 0.0176
258 PULMONARY HYPERTENSION 364 0.0175
259 SENSATION OF FOREIGN BODY 147 0.0174
260 MAJOR DEPRESSION 127 0.0174
261 OSTEOPOROSIS 714 0.0173
262 NECK PAIN 966 0.0173
263 PULMONARY FIBROSIS 331 0.0172
264 TENDERNESS 179 0.0172
265 CARDIAC FLUTTER 111 0.0172
266 IMPAIRED GASTRIC EMPTYING 234 0.0171
267 CHEST DISCOMFORT 1753 0.0171
268 LACRIMATION INCREASED 517 0.0171
269 PHARYNGITIS STREPTOCOCCAL 185 0.0171
270 OCULAR DISCOMFORT 191 0.0170
271 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 815 0.0169
272 FLUID RETENTION 863 0.0169
273 EYE INFECTION 191 0.0169
274 MALNUTRITION 188 0.0168
275 PHARMACEUTICAL PRODUCT COMPLAINT 436 0.0168
276 INFUSION RELATED REACTION 1107 0.0167
277 ATRIAL FLUTTER 133 0.0167
278 BRAIN FOG 261 0.0166
279 MIGRAINE 1587 0.0166
280 SCIATICA 265 0.0166
281 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1177 0.0165
282 VITAMIN D DECREASED 140 0.0164
283 WEIGHT FLUCTUATION 171 0.0163
284 CHOKING SENSATION 90 0.0163
285 PERICARDITIS 274 0.0163
286 BLOOD CALCIUM INCREASED 143 0.0163
287 RIGHT VENTRICULAR FAILURE 114 0.0163
288 RENAL CYST 129 0.0162
289 EYE PRURITUS 545 0.0162
290 LIVER FUNCTION TEST INCREASED 348 0.0162
291 SCOLIOSIS 100 0.0161
292 DRY MOUTH 1307 0.0161
293 PROCEDURAL PAIN 445 0.0160
294 MUSCULOSKELETAL CHEST PAIN 248 0.0160
295 TOOTH INFECTION 211 0.0160
296 PNEUMONIA 5132 0.0158
297 RESTLESS LEGS SYNDROME 288 0.0158
298 DECREASED INTEREST 93 0.0158
299 PEMPHIGUS 197 0.0157
300 DYSPNOEA 8885 0.0157
301 CARDIAC MURMUR 135 0.0156
302 BLOOD CHOLESTEROL INCREASED 727 0.0156
303 HYSTERECTOMY 135 0.0156
304 OBSESSIVE-COMPULSIVE DISORDER 125 0.0156
305 NEPHROPATHY 145 0.0155
306 THERAPEUTIC RESPONSE UNEXPECTED 696 0.0155
307 HOSPICE CARE 153 0.0155
308 BLOOD MAGNESIUM DECREASED 133 0.0154
309 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 264 0.0154
310 PRODUCT DOSE OMISSION IN ERROR 436 0.0154
311 PULMONARY ARTERIAL HYPERTENSION 223 0.0154
312 APPETITE DISORDER 102 0.0154
313 PNEUMOTHORAX 242 0.0152
314 ODYNOPHAGIA 91 0.0152
315 FOOT FRACTURE 289 0.0152
316 INTERVERTEBRAL DISC PROTRUSION 332 0.0152
317 COVID-19 PNEUMONIA 179 0.0151
318 DRY EYE 755 0.0151
319 RESPIRATORY DISORDER 452 0.0151
320 RENAL TUBULAR NECROSIS 147 0.0150
321 EYE DISCHARGE 154 0.0148
322 PNEUMONIA BACTERIAL 136 0.0148
323 MICTURITION URGENCY 169 0.0148
324 PHARYNGITIS 183 0.0147
325 LYMPHOEDEMA 102 0.0147
326 BLOOD IRON DECREASED 175 0.0147
327 NOCTURIA 179 0.0147
328 LIMB INJURY 398 0.0146
329 DIZZINESS POSTURAL 142 0.0146
330 FUNGAL INFECTION 487 0.0146
331 ORAL PAIN 327 0.0146
332 FREQUENT BOWEL MOVEMENTS 394 0.0146
333 MITRAL VALVE INCOMPETENCE 165 0.0146
334 CELLULITIS 733 0.0145
335 PHARYNGEAL SWELLING 141 0.0144
336 RENAL FAILURE 1913 0.0144
337 HEPATIC ENZYME INCREASED 982 0.0144
338 NASOPHARYNGITIS 2650 0.0144
339 EYE PAIN 810 0.0143
340 HYPERSENSITIVITY 2656 0.0143
341 FLANK PAIN 134 0.0143
342 TUBULOINTERSTITIAL NEPHRITIS 267 0.0142
343 ASPIRATION 156 0.0142
344 SKIN SWELLING 123 0.0142
345 HAND FRACTURE 100 0.0141
346 NERVE COMPRESSION 130 0.0141
347 GLAUCOMA 271 0.0141
348 CORONARY ARTERY DISEASE 426 0.0141
349 ORAL DISORDER 103 0.0140
350 DIVERTICULITIS 388 0.0140
351 BACK DISORDER 227 0.0139
352 VENTRICULAR FIBRILLATION 155 0.0139
353 ULCER 222 0.0139
354 RIB FRACTURE 287 0.0139
355 HEAD DISCOMFORT 247 0.0139
356 THYROID DISORDER 215 0.0139
357 SYNOVITIS 251 0.0139
358 BLOOD POTASSIUM DECREASED 418 0.0139
359 PAIN IN JAW 392 0.0138
360 IMPAIRED HEALING 454 0.0138
361 ANAL INCONTINENCE 124 0.0138
362 HAIR DISORDER 113 0.0137
363 URINARY TRACT INFECTION 2338 0.0137
364 SWELLING OF EYELID 86 0.0137
365 ILLNESS 1411 0.0137
366 PRODUCT DISTRIBUTION ISSUE 127 0.0137
367 CONSTIPATION 2985 0.0137
368 HEADACHE 8575 0.0137
369 ACUTE KIDNEY INJURY 2093 0.0137
370 CONTUSION 1316 0.0137
371 GAIT INABILITY 455 0.0136
372 HAEMORRHOIDS 265 0.0136
373 VENTRICULAR EXTRASYSTOLES 141 0.0136
374 PERIPHERAL SWELLING 2091 0.0136
375 CHEST PAIN 2513 0.0136
376 ANXIETY 3857 0.0135
377 PSORIATIC ARTHROPATHY 550 0.0135
378 BLOOD TEST ABNORMAL 190 0.0135
379 WOUND 378 0.0135
380 LUNG INFECTION 210 0.0135
381 TYPE 2 DIABETES MELLITUS 455 0.0135
382 SWELLING FACE 880 0.0135
383 ARTHRITIS 1062 0.0135
384 BLADDER DISORDER 134 0.0135
385 FEELING JITTERY 257 0.0135
386 BODY HEIGHT DECREASED 144 0.0135
387 PRODUCT USE IN UNAPPROVED INDICATION 3330 0.0134
388 SCAB 153 0.0134
389 DYSPEPSIA 1319 0.0134
390 COVID-19 2352 0.0134
391 BLOOD COUNT ABNORMAL 203 0.0134
392 DENTAL CARIES 148 0.0134
393 TEMPERATURE INTOLERANCE 138 0.0134
394 DRUG INTOLERANCE 1290 0.0133
395 CLOSTRIDIUM DIFFICILE COLITIS 140 0.0132
396 RED BLOOD CELL SEDIMENTATION RATE INCREASED 146 0.0132
397 FLUID OVERLOAD 192 0.0132
398 OESOPHAGITIS 144 0.0132
399 CATARACT 784 0.0132
400 GASTROINTESTINAL INFECTION 118 0.0132
401 TRANSIENT ISCHAEMIC ATTACK 444 0.0131
402 PERICARDIAL EFFUSION 304 0.0131
403 INFLUENZA 1464 0.0131
404 PRODUCT DOSE OMISSION ISSUE 3857 0.0131
405 WRIST FRACTURE 157 0.0131
406 TINNITUS 597 0.0130
407 STOMATITIS 788 0.0130
408 LACERATION 122 0.0130
409 MUSCULOSKELETAL PAIN 679 0.0129
410 SUPRAVENTRICULAR TACHYCARDIA 124 0.0129
411 RASH ERYTHEMATOUS 619 0.0129
412 HYPERTENSION 2741 0.0129
413 ONYCHOCLASIS 89 0.0129
414 SKIN INFECTION 145 0.0129
415 PRODUCT ODOUR ABNORMAL 135 0.0129
416 GALLBLADDER DISORDER 230 0.0129
417 JOINT INJURY 275 0.0129
418 POOR QUALITY SLEEP 277 0.0129
419 PULMONARY THROMBOSIS 140 0.0128
420 HYPOTHYROIDISM 410 0.0128
421 CONJUNCTIVITIS 238 0.0128
422 CARDIOGENIC SHOCK 184 0.0128
423 GINGIVAL PAIN 102 0.0128
424 INTENTIONAL DOSE OMISSION 365 0.0128
425 HAIR COLOUR CHANGES 159 0.0128
426 DEPRESSION 2905 0.0128
427 LARGE INTESTINE POLYP 88 0.0127
428 STAPHYLOCOCCAL INFECTION 418 0.0127
429 BACK PAIN 2932 0.0126
430 ANKLE FRACTURE 195 0.0126
431 NEPHROLITHIASIS 576 0.0125
432 OEDEMA PERIPHERAL 1528 0.0125
433 LOWER RESPIRATORY TRACT INFECTION 570 0.0125
434 CHOLECYSTECTOMY 143 0.0125
435 VITREOUS FLOATERS 123 0.0125
436 ECZEMA 652 0.0124
437 SWELLING 1166 0.0124
438 BLISTER 699 0.0124
439 DERMATITIS ATOPIC 656 0.0124
440 SMALL INTESTINAL OBSTRUCTION 153 0.0124
441 AUTOIMMUNE DISORDER 121 0.0124
442 ATRIAL FIBRILLATION 1207 0.0124
443 SURGERY 726 0.0124
444 RECTAL HAEMORRHAGE 531 0.0123
445 PRODUCT DOSE OMISSION 804 0.0123
446 INFECTION 1782 0.0123
447 THROAT TIGHTNESS 332 0.0123
448 SPINAL OPERATION 151 0.0122
449 PANIC ATTACK 446 0.0122
450 HEART RATE INCREASED 1211 0.0122
451 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 670 0.0122
452 CARDIOMEGALY 150 0.0122
453 MUSCLE SPASMS 2237 0.0122
454 TOOTH FRACTURE 134 0.0121
455 EYE HAEMORRHAGE 162 0.0121
456 FRUSTRATION TOLERANCE DECREASED 98 0.0121
457 SKIN FISSURES 237 0.0121
458 FEELING DRUNK 90 0.0121
459 HYPERSOMNIA 347 0.0121
460 SPINAL COMPRESSION FRACTURE 100 0.0121
461 MADAROSIS 140 0.0120
462 ORAL HERPES 235 0.0120
463 ABDOMINAL DISCOMFORT 2014 0.0120
464 RESPIRATORY DEPRESSION 147 0.0120
465 BLOOD ALBUMIN DECREASED 95 0.0120
466 MUSCULAR WEAKNESS 1358 0.0119
467 BLOOD SODIUM DECREASED 225 0.0119
468 INTENTIONAL PRODUCT MISUSE 1045 0.0119
469 PSYCHOLOGICAL TRAUMA 103 0.0119
470 URINARY INCONTINENCE 353 0.0119
471 KNEE OPERATION 117 0.0119
472 LUNG INFILTRATION 105 0.0119
473 CYSTITIS 378 0.0119
474 JOINT SWELLING 1430 0.0118
475 ORTHOSTATIC HYPOTENSION 206 0.0118
476 SPINAL DISORDER 112 0.0118
477 POST PROCEDURAL INFECTION 96 0.0118
478 PULMONARY EMBOLISM 1121 0.0118
479 PALPITATIONS 1380 0.0118
480 WEIGHT DECREASED 3288 0.0118
481 BALANCE DISORDER 1018 0.0118
482 PRESYNCOPE 286 0.0118
483 DIPLOPIA 305 0.0117
484 INCONTINENCE 124 0.0117
485 CLOSTRIDIUM DIFFICILE INFECTION 256 0.0117
486 FLATULENCE 664 0.0117
487 AFFECTIVE DISORDER 92 0.0117
488 HYPOAESTHESIA ORAL 176 0.0117
489 TENDON RUPTURE 144 0.0117
490 HAIR TEXTURE ABNORMAL 156 0.0117
491 FULL BLOOD COUNT DECREASED 234 0.0116
492 MEMORY IMPAIRMENT 1595 0.0116
493 DEEP VEIN THROMBOSIS 754 0.0116
494 ELECTROCARDIOGRAM ABNORMAL 91 0.0116
495 HYPOAESTHESIA 1735 0.0116
496 PRODUCT USE ISSUE 2178 0.0116
497 CHOKING 226 0.0116
498 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 339 0.0116
499 PHARYNGEAL OEDEMA 178 0.0116
500 CHOLELITHIASIS 378 0.0115
501 BIPOLAR DISORDER 125 0.0115
502 QUALITY OF LIFE DECREASED 154 0.0115
503 HAND DEFORMITY 150 0.0114
504 CONDITION AGGRAVATED 3474 0.0114
505 COLITIS 433 0.0114
506 INSOMNIA 3035 0.0114
507 ABDOMINAL DISTENSION 1188 0.0114
508 TOOTHACHE 206 0.0114
509 SINUS TACHYCARDIA 161 0.0113
510 VERTIGO 691 0.0113
511 OCULAR HYPERAEMIA 538 0.0113
512 LYMPHADENOPATHY 401 0.0113
513 BLOOD PRESSURE ABNORMAL 225 0.0113
514 HEAD INJURY 358 0.0113
515 ABDOMINAL PAIN UPPER 2327 0.0113
516 BASAL CELL CARCINOMA 176 0.0113
517 FATIGUE 8780 0.0113
518 DRUG EFFECT LESS THAN EXPECTED 167 0.0113
519 INJURY 791 0.0112
520 TENDONITIS 174 0.0112
521 POOR VENOUS ACCESS 116 0.0112
522 PULMONARY OEDEMA 501 0.0112
523 NEUROPATHY PERIPHERAL 1064 0.0112
524 DIZZINESS 5576 0.0112
525 BLOOD PRESSURE INCREASED 1709 0.0112
526 JOINT DISLOCATION 118 0.0112
527 DISCOMFORT 681 0.0112
528 MUSCULOSKELETAL DISCOMFORT 192 0.0111
529 IMMUNE SYSTEM DISORDER 147 0.0111
530 RESPIRATORY RATE INCREASED 99 0.0111
531 POLLAKIURIA 463 0.0111
532 NERVE INJURY 123 0.0111
533 GASTRITIS 291 0.0110
534 GROIN PAIN 97 0.0110
535 CARDIAC FAILURE CONGESTIVE 887 0.0110
536 ARTHROPATHY 613 0.0110
537 KNEE ARTHROPLASTY 232 0.0110
538 HYPERHIDROSIS 1417 0.0110
539 ANGIOEDEMA 486 0.0110
540 SARS-COV-2 TEST POSITIVE 145 0.0110
541 CYST 136 0.0109
542 HAEMATOCRIT DECREASED 217 0.0109
543 GRIP STRENGTH DECREASED 96 0.0109
544 LEUKOCYTOSIS 197 0.0109
545 EXPOSURE DURING PREGNANCY 676 0.0109
546 FALL 3619 0.0109
547 DISEASE RECURRENCE 516 0.0108
548 HEPATIC STEATOSIS 202 0.0108
549 DYSGEUSIA 804 0.0108
550 VISION BLURRED 1484 0.0108
551 PAIN 6633 0.0108
552 DEHYDRATION 1440 0.0108
553 THROMBOSIS 867 0.0108
554 BONE DISORDER 196 0.0107
555 ORAL DISCOMFORT 149 0.0107
556 SCRATCH 113 0.0107
557 HERNIA 207 0.0107
558 EYE SWELLING 398 0.0107
559 UPPER LIMB FRACTURE 213 0.0107
560 FOOT DEFORMITY 118 0.0106
561 PHOTOPHOBIA 200 0.0106
562 WEIGHT INCREASED 2378 0.0106
563 EYE IRRITATION 611 0.0106
564 RASH PRURITIC 574 0.0106
565 PAIN IN EXTREMITY 3119 0.0106
566 LOWER LIMB FRACTURE 203 0.0106
567 SQUAMOUS CELL CARCINOMA 99 0.0105
568 ASCITES 309 0.0105
569 ARTHRALGIA 4369 0.0105
570 LOCALISED INFECTION 254 0.0105
571 PLEURAL EFFUSION 639 0.0105
572 PARAESTHESIA 1652 0.0105
573 DEPRESSED MOOD 555 0.0105
574 DEAFNESS 274 0.0105
575 SOMNOLENCE 2107 0.0105
576 RED BLOOD CELL COUNT DECREASED 299 0.0104
577 DYSURIA 384 0.0104
578 MUSCLE ATROPHY 132 0.0104
579 BLOOD CALCIUM DECREASED 117 0.0104
580 TRANSFUSION 109 0.0104
581 URTICARIA 1738 0.0104
582 AMNESIA 674 0.0103
583 MOBILITY DECREASED 744 0.0103
584 HYPONATRAEMIA 582 0.0103
585 SKIN HAEMORRHAGE 153 0.0103
586 LIP SWELLING 343 0.0103
587 MENTAL STATUS CHANGES 286 0.0103
588 SKIN LESION 282 0.0103
589 HOT FLUSH 774 0.0103
590 HEART RATE IRREGULAR 232 0.0103
591 TOOTH DISORDER 227 0.0102
592 PLATELET COUNT INCREASED 133 0.0102
593 THIRST 182 0.0102
594 ASTHENIA 3830 0.0102
595 PRODUCT QUALITY ISSUE 1382 0.0102
596 POST PROCEDURAL COMPLICATION 195 0.0101
597 JOINT STIFFNESS 266 0.0101
598 DIARRHOEA 6522 0.0101
599 INFLAMMATION 520 0.0101
600 HEPATOMEGALY 99 0.0101
601 RESPIRATORY DISTRESS 278 0.0101
602 URINE OUTPUT DECREASED 88 0.0101
603 KIDNEY INFECTION 197 0.0100
604 MYALGIA 1706 0.0100
605 RHEUMATOID ARTHRITIS 1135 0.0100
606 FEELING ABNORMAL 2390 0.0100
607 THERAPY NON-RESPONDER 448 0.0100
608 RASH MACULAR 348 0.0099
609 PERIPHERAL COLDNESS 136 0.0099
610 C-REACTIVE PROTEIN INCREASED 360 0.0099
611 INTENTIONAL PRODUCT USE ISSUE 866 0.0099
612 SEPSIS 1102 0.0099
613 PYREXIA 3417 0.0099
614 IMMUNOSUPPRESSION 87 0.0099
615 LIMB DISCOMFORT 305 0.0098
616 PRODUCT USE COMPLAINT 155 0.0098
617 SKIN DISCOLOURATION 452 0.0098
618 DYSSTASIA 287 0.0098
619 SYSTEMIC LUPUS ERYTHEMATOSUS 348 0.0098
620 SLUGGISHNESS 100 0.0098
621 BLOOD URINE PRESENT 186 0.0098
622 DECREASED IMMUNE RESPONSIVENESS 96 0.0098
623 DIABETES MELLITUS INADEQUATE CONTROL 173 0.0098
624 MUSCLE TIGHTNESS 158 0.0097
625 GASTRIC ULCER 185 0.0097
626 EATING DISORDER 207 0.0097
627 HERPES ZOSTER 558 0.0097
628 GASTROINTESTINAL DISORDER 868 0.0097
629 NERVOUSNESS 506 0.0097
630 CHILLS 1134 0.0097
631 COGNITIVE DISORDER 451 0.0096
632 FLUSHING 981 0.0096
633 TREMOR 1601 0.0096
634 PRURITUS 3705 0.0096
635 NAUSEA 7614 0.0096
636 HUNGER 134 0.0096
637 DISTURBANCE IN ATTENTION 518 0.0096
638 MUSCLE SPASTICITY 118 0.0096
639 OVARIAN CYST 96 0.0096
640 VOMITING 4514 0.0096
641 ABDOMINAL PAIN 2227 0.0096
642 GASTROINTESTINAL PAIN 105 0.0095
643 CARDIOMYOPATHY 141 0.0095
644 PSYCHOMOTOR HYPERACTIVITY 158 0.0095
645 DRUG ADMINISTRATION ERROR 292 0.0095
646 THERAPEUTIC PRODUCT EFFECT DECREASED 426 0.0095
647 FEELING HOT 583 0.0095
648 RASH 4131 0.0095
649 ANAPHYLACTIC REACTION 523 0.0095
650 SCAR 162 0.0095
651 HEART RATE DECREASED 332 0.0094
652 PHOTOSENSITIVITY REACTION 156 0.0094
653 GLOMERULAR FILTRATION RATE DECREASED 116 0.0094
654 LETHARGY 543 0.0094
655 RECALLED PRODUCT ADMINISTERED 90 0.0094
656 WHITE BLOOD CELL COUNT INCREASED 362 0.0094
657 PRESCRIBED UNDERDOSE 188 0.0094
658 DYSPHAGIA 893 0.0094
659 DISABILITY 186 0.0094
660 HIP ARTHROPLASTY 144 0.0094
661 BLOOD TRIGLYCERIDES INCREASED 166 0.0094
662 ROAD TRAFFIC ACCIDENT 393 0.0094
663 EXPIRED PRODUCT ADMINISTERED 312 0.0094
664 EYE DISORDER 308 0.0094
665 DIABETES MELLITUS 714 0.0094
666 EOSINOPHILIA 164 0.0093
667 SENSORY DISTURBANCE 150 0.0093
668 THINKING ABNORMAL 174 0.0093
669 SKIN ULCER 241 0.0093
670 UROSEPSIS 86 0.0093
671 DERMATITIS 195 0.0093
672 EPILEPSY 284 0.0093
673 HYPOPHAGIA 237 0.0093
674 DECREASED APPETITE 2153 0.0093
675 FEEDING DISORDER 188 0.0093
676 BLOOD UREA INCREASED 155 0.0092
677 BLOOD POTASSIUM INCREASED 150 0.0092
678 MALAISE 4043 0.0092
679 UPPER GASTROINTESTINAL HAEMORRHAGE 154 0.0091
680 MUSCLE TWITCHING 211 0.0091
681 PERSONALITY CHANGE 85 0.0091
682 DEVICE FAILURE 139 0.0091
683 BLOOD PRESSURE DECREASED 606 0.0091
684 PRODUCT PRESCRIBING ERROR 217 0.0091
685 NIGHTMARE 315 0.0091
686 HAEMATOCHEZIA 502 0.0091
687 EXPOSURE VIA SKIN CONTACT 235 0.0091
688 IRRITABILITY 541 0.0090
689 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1621 0.0090
690 GAIT DISTURBANCE 1721 0.0090
691 GASTROENTERITIS 131 0.0090
692 ELECTROLYTE IMBALANCE 104 0.0089
693 HYPOKALAEMIA 412 0.0089
694 UNEVALUABLE EVENT 673 0.0089
695 BONE PAIN 521 0.0089
696 LABORATORY TEST ABNORMAL 262 0.0089
697 MUSCULOSKELETAL STIFFNESS 776 0.0088
698 FAECES DISCOLOURED 192 0.0088
699 INTRAOCULAR PRESSURE INCREASED 113 0.0088
700 BLOOD PRESSURE FLUCTUATION 212 0.0088
701 RESPIRATORY FAILURE 644 0.0088
702 THERAPY CESSATION 453 0.0088
703 COAGULOPATHY 147 0.0088
704 INCORRECT PRODUCT ADMINISTRATION DURATION 191 0.0088
705 CONFUSIONAL STATE 1416 0.0088
706 RASH PAPULAR 196 0.0087
707 RENAL DISORDER 406 0.0087
708 BURNING SENSATION 611 0.0087
709 SYNCOPE 871 0.0087
710 TACHYCARDIA 773 0.0087
711 ANAEMIA 1654 0.0087
712 INFLUENZA LIKE ILLNESS 711 0.0086
713 SKIN DISORDER 288 0.0086
714 DRY SKIN 1152 0.0086
715 GASTRIC DISORDER 296 0.0086
716 HYPOACUSIS 371 0.0086
717 BLOOD ALKALINE PHOSPHATASE INCREASED 214 0.0086
718 VENTRICULAR TACHYCARDIA 142 0.0086
719 HALLUCINATION 648 0.0086
720 THERAPEUTIC RESPONSE SHORTENED 285 0.0086
721 SPINAL FRACTURE 172 0.0086
722 COLD SWEAT 151 0.0086
723 CORONARY ARTERY OCCLUSION 117 0.0085
724 ILL-DEFINED DISORDER 517 0.0085
725 OSTEOMYELITIS 154 0.0085
726 SKIN EXFOLIATION 716 0.0085
727 PNEUMONIA ASPIRATION 212 0.0085
728 SPLENOMEGALY 99 0.0084
729 VISUAL IMPAIRMENT 1046 0.0084
730 ERYTHEMA 1726 0.0084
731 INCREASED APPETITE 160 0.0084
732 MASS 117 0.0084
733 TREATMENT NONCOMPLIANCE 458 0.0084
734 MOOD ALTERED 228 0.0084
735 TOOTH EXTRACTION 104 0.0083
736 THERAPEUTIC RESPONSE DECREASED 506 0.0083
737 HYPOTENSION 1674 0.0083
738 IMPAIRED DRIVING ABILITY 94 0.0083
739 MUSCULOSKELETAL DISORDER 157 0.0082
740 GASTROINTESTINAL HAEMORRHAGE 688 0.0082
741 EUPHORIC MOOD 84 0.0082
742 ACTIVITIES OF DAILY LIVING IMPAIRED 162 0.0082
743 CHOLECYSTITIS 97 0.0081
744 THERAPY INTERRUPTED 581 0.0081
745 COMPLICATION ASSOCIATED WITH DEVICE 118 0.0081
746 FEELING COLD 225 0.0081
747 CRYING 293 0.0081
748 INTERNAL HAEMORRHAGE 92 0.0080
749 ANGER 272 0.0080
750 HEPATIC CIRRHOSIS 151 0.0080
751 DRUG INEFFECTIVE 10581 0.0080
752 GENERAL PHYSICAL HEALTH DETERIORATION 927 0.0080
753 GINGIVAL BLEEDING 109 0.0080
754 MOUTH ULCERATION 168 0.0080
755 ALOPECIA 1565 0.0080
756 INJECTION SITE PRURITUS 532 0.0079
757 CARDIAC DISORDER 743 0.0079
758 INJECTION SITE RASH 243 0.0079
759 EMOTIONAL DISTRESS 956 0.0079
760 INTESTINAL OBSTRUCTION 297 0.0079
761 PARANOIA 135 0.0078
762 COLITIS ULCERATIVE 350 0.0078
763 SEIZURE 902 0.0078
764 BLOOD PRESSURE SYSTOLIC INCREASED 152 0.0078
765 BODY TEMPERATURE INCREASED 159 0.0078
766 FEMUR FRACTURE 241 0.0078
767 MOOD SWINGS 248 0.0078
768 PRODUCT ADMINISTRATION ERROR 157 0.0078
769 PELVIC PAIN 141 0.0078
770 HIP FRACTURE 249 0.0077
771 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 360 0.0077
772 URINARY RETENTION 257 0.0077
773 ERUCTATION 149 0.0077
774 WHITE BLOOD CELL COUNT DECREASED 834 0.0077
775 IMPAIRED WORK ABILITY 164 0.0077
776 HOSPITALISATION 1177 0.0077
777 ADVERSE DRUG REACTION 687 0.0076
778 ABNORMAL DREAMS 211 0.0076
779 DRUG INTERACTION 1211 0.0076
780 PSORIASIS 996 0.0076
781 CHROMATURIA 172 0.0076
782 SPEECH DISORDER 399 0.0076
783 INJECTION SITE SWELLING 583 0.0076
784 DEVICE OCCLUSION 107 0.0076
785 SPINAL PAIN 89 0.0076
786 LOSS OF CONSCIOUSNESS 973 0.0076
787 HAEMATURIA 260 0.0076
788 ABSCESS 121 0.0076
789 HAEMOGLOBIN DECREASED 778 0.0076
790 BONE DENSITY DECREASED 237 0.0076
791 TREATMENT FAILURE 626 0.0075
792 INJECTION SITE URTICARIA 185 0.0075
793 ASPARTATE AMINOTRANSFERASE INCREASED 399 0.0075
794 BLOOD CREATININE INCREASED 490 0.0075
795 HEMIPARESIS 127 0.0075
796 OFF LABEL USE 6558 0.0075
797 HAEMATOMA 194 0.0075
798 MULTIPLE ORGAN DYSFUNCTION SYNDROME 212 0.0075
799 MALIGNANT MELANOMA 100 0.0075
800 LIVER FUNCTION TEST ABNORMAL 217 0.0075
801 PNEUMONITIS 203 0.0074
802 INJECTION SITE DISCOLOURATION 93 0.0074
803 SUICIDAL IDEATION 677 0.0074
804 PRURITUS GENERALISED 159 0.0073
805 INJECTION SITE BRUISING 586 0.0073
806 DYSARTHRIA 276 0.0073
807 LIVER INJURY 179 0.0073
808 ABNORMAL BEHAVIOUR 288 0.0073
809 PRODUCT TASTE ABNORMAL 98 0.0072
810 FEAR 194 0.0072
811 DEVICE RELATED INFECTION 111 0.0072
812 PRODUCT SUBSTITUTION ISSUE 415 0.0072
813 CYANOSIS 113 0.0072
814 ACUTE MYOCARDIAL INFARCTION 211 0.0071
815 MATERNAL EXPOSURE DURING PREGNANCY 636 0.0071
816 DRUG EFFECT INCOMPLETE 259 0.0071
817 GENERALISED OEDEMA 88 0.0071
818 LOCAL SWELLING 123 0.0070
819 HYPOMAGNESAEMIA 98 0.0070
820 RESTLESSNESS 257 0.0070
821 EMOTIONAL DISORDER 215 0.0070
822 APHASIA 210 0.0069
823 ENCEPHALOPATHY 170 0.0069
824 HYPERTHYROIDISM 100 0.0069
825 LYMPHOCYTE COUNT DECREASED 122 0.0069
826 COORDINATION ABNORMAL 96 0.0069
827 MULTIPLE FRACTURES 113 0.0069
828 UNRESPONSIVE TO STIMULI 177 0.0069
829 EJECTION FRACTION DECREASED 106 0.0068
830 DISORIENTATION 270 0.0068
831 HAEMATEMESIS 172 0.0068
832 SKIN CANCER 146 0.0068
833 INJECTION SITE ERYTHEMA 841 0.0068
834 TACHYPNOEA 91 0.0067
835 EXTRA DOSE ADMINISTERED 271 0.0067
836 HYPERGLYCAEMIA 242 0.0066
837 MENTAL DISORDER 289 0.0066
838 INCORRECT DRUG ADMINISTRATION DURATION 186 0.0066
839 ANGINA PECTORIS 188 0.0066
840 HYPOKINESIA 95 0.0065
841 PAIN OF SKIN 174 0.0065
842 DEVICE DELIVERY SYSTEM ISSUE 176 0.0064
843 INJECTION SITE PAIN 1968 0.0064
844 PLATELET COUNT DECREASED 682 0.0064
845 ALANINE AMINOTRANSFERASE INCREASED 392 0.0064
846 INJECTION SITE MASS 236 0.0064
847 INJECTION SITE REACTION 439 0.0064
848 APATHY 93 0.0064
849 COLON CANCER 95 0.0064
850 HALLUCINATION, VISUAL 134 0.0063
851 GLYCOSYLATED HAEMOGLOBIN INCREASED 160 0.0063
852 PRODUCT PRESCRIBING ISSUE 138 0.0063
853 ABDOMINAL PAIN LOWER 160 0.0063
854 TOOTH LOSS 131 0.0063
855 LYMPHOPENIA 89 0.0063
856 MENTAL IMPAIRMENT 152 0.0063
857 ACCIDENTAL EXPOSURE TO PRODUCT 645 0.0063
858 RENAL FAILURE ACUTE 265 0.0062
859 ERECTILE DYSFUNCTION 160 0.0062
860 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1262 0.0062
861 DRUG DOSE OMISSION 1027 0.0062
862 BLOOD GLUCOSE DECREASED 298 0.0062
863 AGGRESSION 310 0.0062
864 DELUSION 96 0.0062
865 RENAL IMPAIRMENT 519 0.0062
866 MOVEMENT DISORDER 198 0.0062
867 DYSKINESIA 250 0.0061
868 TRANSAMINASES INCREASED 136 0.0061
869 MULTIPLE SCLEROSIS RELAPSE 418 0.0061
870 THROMBOCYTOPENIA 678 0.0061
871 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 431 0.0061
872 UNDERDOSE 440 0.0060
873 DELIRIUM 209 0.0060
874 PANCREATITIS 318 0.0060
875 RASH GENERALISED 155 0.0060
876 AGITATION 437 0.0059
877 ADVERSE EVENT 547 0.0059
878 MANIA 97 0.0059
879 MULTIPLE SCLEROSIS 281 0.0059
880 DEMENTIA 164 0.0059
881 HYPERKALAEMIA 205 0.0058
882 DEVICE DEFECTIVE 101 0.0058
883 HYPOGLYCAEMIA 282 0.0058
884 INCORRECT DOSE ADMINISTERED 1324 0.0058
885 ARRHYTHMIA 274 0.0058
886 BLOOD BILIRUBIN INCREASED 156 0.0058
887 DEVICE USE ISSUE 101 0.0058
888 INTERNATIONAL NORMALISED RATIO INCREASED 164 0.0057
889 NEEDLE ISSUE 167 0.0057
890 HALLUCINATION, AUDITORY 91 0.0057
891 CARDIAC FAILURE 459 0.0057
892 DEVICE ISSUE 511 0.0057
893 CEREBROVASCULAR ACCIDENT 962 0.0057
894 BLINDNESS 231 0.0057
895 PRODUCT PREPARATION ERROR 116 0.0056
896 BLOOD GLUCOSE INCREASED 1057 0.0056
897 HAEMORRHAGE 586 0.0056
898 FEBRILE NEUTROPENIA 371 0.0056
899 SEDATION 146 0.0056
900 WITHDRAWAL SYNDROME 233 0.0055
901 PANCREATITIS ACUTE 124 0.0055
902 LIVER DISORDER 242 0.0055
903 ACCIDENTAL OVERDOSE 197 0.0054
904 DRUG EFFECT DECREASED 289 0.0054
905 PALLOR 146 0.0054
906 PRODUCT PHYSICAL ISSUE 108 0.0053
907 DEVICE BREAKAGE 216 0.0053
908 MYOCARDIAL INFARCTION 928 0.0053
909 SEPTIC SHOCK 230 0.0053
910 HYPOCALCAEMIA 100 0.0053
911 PRODUCT AVAILABILITY ISSUE 120 0.0053
912 OSTEONECROSIS 173 0.0053
913 INJECTION SITE WARMTH 107 0.0052
914 BRADYCARDIA 272 0.0051
915 PLASMA CELL MYELOMA 200 0.0051
916 BLOOD GLUCOSE ABNORMAL 94 0.0051
917 DEVICE DISLOCATION 220 0.0051
918 ABASIA 125 0.0051
919 VISUAL ACUITY REDUCED 165 0.0050
920 MELAENA 109 0.0049
921 PSYCHOTIC DISORDER 146 0.0049
922 FRACTURE 93 0.0049
923 DISEASE PROGRESSION 570 0.0048
924 DEVICE MALFUNCTION 334 0.0047
925 NERVOUS SYSTEM DISORDER 147 0.0047
926 WRONG TECHNIQUE IN DRUG USAGE PROCESS 170 0.0047
927 MEDICATION ERROR 258 0.0046
928 PROTEINURIA 87 0.0046
929 NO ADVERSE EVENT 822 0.0045
930 INJECTION SITE HAEMORRHAGE 362 0.0045
931 DEVICE LEAKAGE 194 0.0045
932 INTERSTITIAL LUNG DISEASE 216 0.0045
933 LUNG NEOPLASM MALIGNANT 182 0.0044
934 ACNE 334 0.0044
935 HEPATIC FAILURE 131 0.0043
936 PREGNANCY 87 0.0043
937 PRODUCT DISPENSING ERROR 94 0.0043
938 NEUTROPHIL COUNT DECREASED 175 0.0043
939 OSTEONECROSIS OF JAW 106 0.0043
940 CONVULSION 244 0.0043
941 HEPATITIS 109 0.0043
942 STEVENS-JOHNSON SYNDROME 94 0.0042
943 ELECTROCARDIOGRAM QT PROLONGED 152 0.0042
944 INCORRECT DOSE ADMINISTERED BY DEVICE 110 0.0042
945 DEVICE USE ERROR 145 0.0042
946 OVERDOSE 900 0.0042
947 DRUG-INDUCED LIVER INJURY 130 0.0041
948 CARDIOVASCULAR DISORDER 105 0.0041
949 PANCYTOPENIA 231 0.0041
950 CARDIAC ARREST 340 0.0041
951 SKIN IRRITATION 186 0.0041
952 APPLICATION SITE PAIN 89 0.0040
953 CEREBRAL HAEMORRHAGE 144 0.0040
954 ANAPHYLACTIC SHOCK 101 0.0039
955 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 91 0.0039
956 JAUNDICE 105 0.0039
957 TARDIVE DYSKINESIA 109 0.0039
958 RESPIRATORY ARREST 104 0.0038
959 APPLICATION SITE PRURITUS 85 0.0037
960 NEOPLASM MALIGNANT 249 0.0037
961 METABOLIC ACIDOSIS 118 0.0037
962 DEPRESSED LEVEL OF CONSCIOUSNESS 145 0.0037
963 LEUKOPENIA 183 0.0037
964 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 122 0.0036
965 VAGINAL HAEMORRHAGE 154 0.0035
966 BLOOD CREATINE PHOSPHOKINASE INCREASED 102 0.0035
967 DEATH 3017 0.0035
968 LACTIC ACIDOSIS 110 0.0034
969 INCORRECT ROUTE OF DRUG ADMINISTRATION 121 0.0034
970 NEOPLASM PROGRESSION 117 0.0034
971 RHABDOMYOLYSIS 140 0.0034
972 CARDIO-RESPIRATORY ARREST 140 0.0033
973 NEUTROPENIA 454 0.0033
974 APPLICATION SITE ERYTHEMA 87 0.0033
975 SKIN BURNING SENSATION 225 0.0031
976 SUICIDE ATTEMPT 182 0.0030
977 DRUG EXPOSURE DURING PREGNANCY 102 0.0030
978 DRUG WITHDRAWAL SYNDROME 233 0.0027
979 MALIGNANT NEOPLASM PROGRESSION 271 0.0026
980 DRUG DEPENDENCE 424 0.0026
981 PRODUCT STORAGE ERROR 218 0.0025
982 ABORTION SPONTANEOUS 98 0.0024
983 DRUG ABUSE 200 0.0024
984 DRUG DOSE OMISSION BY DEVICE 178 0.0023
985 BREAST CANCER 208 0.0022
986 PROSTATE CANCER 173 0.0021
987 COMA 91 0.0019
988 DEVICE DIFFICULT TO USE 123 0.0019
989 TOXICITY TO VARIOUS AGENTS 262 0.0016
990 INTENTIONAL OVERDOSE 94 0.0015
991 DEVICE EXPULSION 91 0.0014
992 FOETAL EXPOSURE DURING PREGNANCY 94 0.0012